Pablo J Cagnoni

President, R&D

Pablo J Cagnoni (President, R&D) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Incyte Corporation (INCY). The largest single filing was $2.8M of INCY (23,218 sh across 2 lots, as filed), executed Sep 15.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 8 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$14.1M

shares × price, as filed

Last traded

Sep 15

Filed Sep 17

Median ADV $231.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $14.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 8 filings

Sector per market data · by filing · past 12 months

Most traded names

INCY

Incyte Corporation INCY · 0 buys · 8 sells 8 filings

Recent filings

INCYSALE Incyte Corporation View filing → $2.8M
23,218 sh across 2 lots
Exec Sep 15
Filed Sep 17 · 4:04 PM ET INCYSALE Incyte Corporation View filing → $1.4M
10,801 sh × $125.56
Exec Aug 19
Filed Aug 20 · 5:15 PM ET INCYSALE Incyte Corporation View filing → $1.3M
10,803 sh × $120.04
Exec Aug 12
Filed Aug 14 · 4:01 PM ET INCYSALE Incyte Corporation View filing → $1.3M
10,640 sh × $122.69
Exec Aug 5
Filed Aug 7 · 4:02 PM ET INCYSALE Incyte Corporation View filing → $1.9M
15,888 sh × $119.70
Exec Jul 31
Filed Aug 4 · 4:04 PM ET INCYSALE Incyte Corporation View filing → $1.8M
18,667 sh × $96.50
Exec Apr 17
Filed Apr 21 · 5:30 PM ET INCYSALE Incyte Corporation View filing → $1.8M
18,667 sh × $94.24
Exec Mar 17
Filed Mar 19 · 5:30 PM ET INCYSALE Incyte Corporation View filing → $1.9M
18,668 sh × $100.91
Exec Feb 19
Filed Feb 23 · 5:30 PM ET